Biosimilar Pricing and Competition: How Political Visibility Shapes Biologic Pricing after Loss of Exclusivity Introduction Biologics have reshaped the treatment landscape across a broad Read More »
Navigate access policies Reflections on The Initial Impact of COVID-19 on Global Market Access Activities Read More
Communicate the value How engaging with affiliates enabled the development of a fully adaptable budget impact model to support successful launches across all Wave 1 markets Read More
Communicate the value How a DELPHI survey informed the key inputs of a health economic model to support the launch of a breakthrough specialty product Read More
